Euroapi SAS
Research Euroapi SAS (EAPI) on Bullrun: market cap EUR 89.07M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEAPI
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 89.07M
- Financial periodFY2025
- RevenueEUR 852.60M
- Revenue growth-7.2%
- Net income-EUR 211.20M
- Free cash flowEUR 50.00M
- Gross margin17.0%
Valuation Snapshot
latest market cap is EUR 89.07M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 852.60M | -EUR 211.20M | EUR 50.00M | 17.0% | -2.23 | EUR 113.80M | EUR 65.40M | EUR 788.20M |
| FY2024 | EUR 919.20M | -EUR 130.60M | EUR 14.90M | 15.5% | -1.38 | EUR 73.00M | EUR 69.10M | EUR 983.60M |
| FY2023 | EUR 1.02B | -EUR 189.70M | -EUR 127.70M | 16.2% | -2.02 | EUR 34.50M | EUR 225.50M | EUR 927.80M |
| FY2022 | EUR 980.90M | -EUR 15.00M | -EUR 122.60M | 18.0% | -0.16 | EUR 74.50M | EUR 120.80M | EUR 1.11B |
| FY2021 | n/a | n/a | n/a | n/a | -0.09 | EUR 10.30M | n/a | EUR 1.02B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-29 | EUR 89.07M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Euroapi SAS
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that use solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Euroapi SAS's market cap?
Euroapi SAS's market capitalization is EUR 89.07M.
What does Euroapi SAS do?
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that use solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; and steroids and hormones substances.